Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yasmin Rosshandler, Ann Q. Shen, Jorge Cortes & Hanna Jean Khoury. (2016) Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia. Expert Review of Hematology 9:5, pages 419-424.
Read now
Read now
Argun Akcakanat, David S Hong & Funda Meric-Bernstam. (2014) Targeting translation initiation in breast cancer. Translation 2:1.
Read now
Read now
Articles from other publishers (3)
Aleksandra Sochacka-Ćwikła, Marcin Mączyński & Andrzej Regiec. (2021) FDA-Approved Drugs for Hematological Malignancies—The Last Decade Review. Cancers 14:1, pages 87.
Crossref
Crossref
Juha H. Siitonen, Lu Yu, Jakob Danielsson, Giovanni Di Gregorio & Peter Somfai. (2018)
Formal Synthesis of
ent
-Cephalotaxine Using a One-Pot Parham–Aldol Sequence
. The Journal of Organic Chemistry 83:18, pages 11318-11322.
Crossref
Crossref
Seiichi Sakamoto, Tomofumi Miyamoto, Kazuteru Usui, Hiroyuki Tanaka & Satoshi Morimoto. (2017) Sodium-Periodate-Mediated Harringtonine Derivatives and Their Antiproliferative Activity against HL-60 Acute Leukemia Cells. Journal of Natural Products 81:1, pages 34-40.
Crossref
Crossref